大元泵業(603757.SH):液冷溫控業務下遊客戶包括維諦技術、英維克等各類型及各領域客戶
格隆匯8月4日丨大元泵業(603757.SH)在互動平臺表示,公司液冷溫控業務下遊客戶包括維諦技術、英維克、中興通訊、曙光數創、同飛股份、零跑汽車、中車株洲等各類型及各領域客戶;2024年,公司液冷溫控業務實現收入約0.9億元,同比增長超過80%;2025年第一季度,公司液冷溫控業務實現收入約0.3億元,同比實現翻倍以上增長。 隨着全球產業及國民經濟各環節電氣化進程方興未艾,儲能風電、算力服務、新能源汽車、電力電源設備、激光反無人機等高功耗領域溫控需求蓬勃發展,公司將繼續加大研發力度、完善產品形態和競爭力,提升產能規模,以關鍵客戶爲突破點,提升市場佔有率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.